Precision Dose recalls ranitidine products

Precision Dose, a South Beloit, Ill.-based prescription drug supplier, is recalling five lots of its ranitidine oral solution after finding a potential human carcinogen. 

Precision Dose initiated the recall in response to Amneal's recall, which included lots repackaged by Precision Dose. 

The drugmaker found levels of N-Nitrosodimethylamine in the product higher than the FDA accepts.

Consumers, distributors and retailers with the affected lots should stop use and call Precision dose to obtain a return packet. 

Precision Dose has not received any adverse event reports related to the recall. 

Read the full news release here

More articles on pharmacy:
AHA, CVS Health backed secretive anti-pharma group
EpiPen, Humira among drugs Warren wants to regulate
31 drugmakers at high risk for bankruptcy in 2020

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars